Perceptions and Representations of Cancer Chemotherapy

Lung Cancer Clinical Trial

— chemotherapy  

Official title:

Perceptions and Representations of Cancer Chemotherapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02851160
• Other study ID #: RECHMPL16_0208
• Status: Completed
• Phase: N/A
• First received: June 30, 2016
• Last updated: July 27, 2016
• Start date: March 2015
• Est. completion date: December 2015

Study information

• Verified date: March 2015
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santéFrance: Commission nationale de l'informatique et des libertés
• Study type: Observational

Clinical Trial Summary

Qualitative study on data from interviews such patients, relatives and doctors involved in the implementation of cancer care. Framework type of method using grounded theory

Description:

The word chemotherapy itself, because it belongs to the secular knowledge and therefore Doxa is a hard word, which stores what it is stable, common and therefore impersonal. It has the properties of a symbol, that is to say that joint several meanings, some of which are contradictory.

The objective of the research:

To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational.

To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment

• 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery

• 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Exclusion Criteria:

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Lung Cancer

Intervention

Other:
• semi-structured interview conducted by a clinical psychologist
semi-structured interview conducted by a clinical psychologist
• semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The semi-structured interview	The interview will be analyzed in a framework type of method (grounded theory) in accordance with the guidelines coreq.	1 day (day of inclusion)	No